Vir Biotechnology Inc.

Clinical research in chronic hepatitis B centers on investigational antiviral approaches aimed at controlling persistent infection and reducing viral activity. The sponsor’s work in this area includes studies of novel regimens designed to address long-standing HBV infection and related treatment outcomes.

• Antiviral treatment for persistent HBV infection
• Viral suppression and serologic response
• Safety and tolerability of combination regimens

These trials reflect a focus on chronic viral liver disease and the development of therapies with potential to improve disease control in hepatology.